Here we investigated the roles of non-Smad pathway (ERK1/2) and Smad in TGF-β tumor promoting and suppressing activities in intrahepatic cholangiocarcinoma (ICC) cells. This evidence concerns the gene MAPK3 and intrahepatic cholangiocarcinoma.